Search Results - "Denning, David W"

Refine Results
  1. 1

    The WHO fungal priority pathogens list as a game-changer by Fisher, Matthew C., Denning, David W.

    Published in Nature reviews. Microbiology (01-04-2023)
    “…Invasive fungal diseases are on the increase globally. The World Health Organization fungal priority pathogens list highlights fungi of critical or high…”
    Get full text
    Journal Article
  2. 2

    How to bolster the antifungal pipeline by Denning, David W, Bromley, Michael J

    “…Few drugs are coming to market, but opportunities for drug development exist About 1.2 billion people worldwide are estimated to suffer from a fungal disease (…”
    Get full text
    Journal Article
  3. 3

    Pulmonary cryptococcosis: A review of pathobiology and clinical aspects by Setianingrum, Findra, Rautemaa-Richardson, Riina, Denning, David W

    Published in Medical mycology (Oxford) (01-02-2019)
    “…Pulmonary cryptococcosis is an important opportunistic invasive mycosis in immunocompromised patients, but it is also increasingly seen in immunocompetent…”
    Get full text
    Journal Article
  4. 4

    Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis by Rajasingham, Radha, Dr, Smith, Rachel M, MD, Park, Benjamin J, MD, Jarvis, Joseph N, MRCP, Govender, Nelesh P, MMed, Chiller, Tom M, MD, Denning, David W, Prof, Loyse, Angela, MD [Res], Boulware, David R, MD

    Published in The Lancet infectious diseases (01-08-2017)
    “…Summary Background Cryptococcus is the most common cause of meningitis in adults living with HIV in sub-Saharan Africa. Global burden estimates are crucial to…”
    Get full text
    Journal Article
  5. 5

    The global distribution of actinomycetoma and eumycetoma by Emery, Darcy, Denning, David W

    Published in PLoS neglected tropical diseases (01-09-2020)
    “…Background Mycetoma, a chronic infection of the skin and underlying structures, affects those with a close relationship to the land, often in resource-poor…”
    Get full text
    Journal Article
  6. 6

    Tackling human fungal infections by Brown, Gordon D, Denning, David W, Levitz, Stuart M

    “…Fungi infect billions of people every year, yet their contribution to the global burden of disease is largely unrecognized. Most are “relatively” minor…”
    Get full text
    Journal Article
  7. 7

    Innate and Adaptive Immune Defects in Chronic Pulmonary Aspergillosis by Bongomin, Felix, Harris, Chris, Foden, Philip, Kosmidis, Chris, Denning, David W

    Published in Journal of fungi (Basel) (29-05-2017)
    “…We evaluated the expression of biomarkers of innate and adaptive immune response in correlation with underlying conditions in 144 patients with chronic…”
    Get full text
    Journal Article
  8. 8

    Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision by Bongomin, Felix, Gago, Sara, Oladele, Rita O, Denning, David W

    Published in Journal of fungi (Basel) (18-10-2017)
    “…Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are still a neglected topic by public health authorities even though…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management by Denning, David W, Cadranel, Jacques, Beigelman-Aubry, Catherine, Ader, Florence, Chakrabarti, Arunaloke, Blot, Stijn, Ullmann, Andrew J, Dimopoulos, George, Lange, Christoph

    Published in The European respiratory journal (01-01-2016)
    “…Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary disease, complicating many other respiratory disorders, thought to affect ~240…”
    Get full text
    Journal Article
  11. 11

    Estimation of the burden of chronic and allergic pulmonary aspergillosis in India by Agarwal, Ritesh, Denning, David W, Chakrabarti, Arunaloke

    Published in PloS one (05-12-2014)
    “…It would be of considerable interest to clinicians if the burden of chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) in…”
    Get full text
    Journal Article
  12. 12

    Therapy for fungal diseases: opportunities and priorities by Denning, David W, Hope, William W

    Published in Trends in microbiology (Regular ed.) (01-05-2010)
    “…This article provides a perspective on the current status of drug therapy for invasive fungal diseases, together with priorities for the future development of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis by Bongomin, Felix, Harris, Chris, Hayes, Gemma, Kosmidis, Chris, Denning, David W

    Published in PloS one (10-04-2018)
    “…There is a paucity of evidence surrounding the optimal antifungal therapy for use in chronic pulmonary aspergillosis (CPA) and the duration of therapy remains…”
    Get full text
    Journal Article
  15. 15

    Hidden killers: human fungal infections by Brown, Gordon D, Denning, David W, Gow, Neil A R, Levitz, Stuart M, Netea, Mihai G, White, Theodore C

    Published in Science translational medicine (19-12-2012)
    “…Although fungal infections contribute substantially to human morbidity and mortality, the impact of these diseases on human health is not widely appreciated…”
    Get more information
    Journal Article
  16. 16

    Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis by Armstead, Joanne, Morris, Julie, Denning, David W

    Published in PloS one (10-06-2014)
    “…Aspergillus spp. can lead to allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitisation and Aspergillus bronchitis in CF. The relative…”
    Get full text
    Journal Article
  17. 17

    Comparison of six Aspergillus -specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA) by Page, Iain D, Richardson, Malcolm D, Denning, David W

    Published in The Journal of infection (01-02-2016)
    “…Summary Objectives Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million persons worldwide. Aspergillus -specific IgG is a key component in…”
    Get full text
    Journal Article
  18. 18

    Global burden of chronic pulmonary aspergillosis complicating sarcoidosis by DENNING, David W, PLEUVRY, Alex, COLE, Donald C

    Published in The European respiratory journal (01-03-2013)
    “…Chronic pulmonary aspergillosis (CPA) may complicate pulmonary sarcoidosis. We re-estimated the global burden of sarcoidosis and the burden of CPA complicating…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Predictors of mortality in chronic pulmonary aspergillosis by Lowes, David, Al-Shair, Khaled, Newton, Pippa J, Morris, Julie, Harris, Chris, Rautemaa-Richardson, Riina, Denning, David W

    Published in The European respiratory journal (01-02-2017)
    “…Chronic pulmonary aspergillosis (CPA) is a chronic progressive infection that destroys lung tissue in non-immunocompromised patients. Contemporary series…”
    Get full text
    Journal Article